180 related articles for article (PubMed ID: 11055836)
1. Chemoprevention of breast cancer by tamoxifen: risks and opportunities.
Smith LL; Brown K; Carthew P; Lim CK; Martin EA; Styles J; White IN
Crit Rev Toxicol; 2000 Sep; 30(5):571-94. PubMed ID: 11055836
[TBL] [Abstract][Full Text] [Related]
2. The tamoxifen dilemma.
White IN
Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen.
Brown K
Expert Opin Drug Saf; 2002 Sep; 1(3):253-67. PubMed ID: 12904141
[TBL] [Abstract][Full Text] [Related]
4. The role of tamoxifen in the treatment and prevention of breast cancer.
Jordan VC
Curr Probl Cancer; 1992; 16(3):129-76. PubMed ID: 1582240
[TBL] [Abstract][Full Text] [Related]
5. Anti-oestrogenic drugs and endometrial cancers.
White IN
Toxicol Lett; 2001 Mar; 120(1-3):21-9. PubMed ID: 11323158
[TBL] [Abstract][Full Text] [Related]
6. The breast cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast cancer.
Overmoyer BA
Cleve Clin J Med; 1999 Jan; 66(1):33-40. PubMed ID: 9926629
[TBL] [Abstract][Full Text] [Related]
7. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen in postmenopausal women a safety perspective.
Robinson E; Kimmick GG; Muss HB
Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
[TBL] [Abstract][Full Text] [Related]
10. Status of antiestrogen breast cancer prevention trials.
Powles TJ
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
[TBL] [Abstract][Full Text] [Related]
11. [Tamoxifen and breast cancer: is everything known already?].
Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
[No Abstract] [Full Text] [Related]
12. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.
Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG
J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236
[TBL] [Abstract][Full Text] [Related]
13. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogen therapy: uncertainties and risk assessment.
Smith LL; White IN
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of tamoxifen therapy.
Assikis VJ; Jordan VC
Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):21-3. PubMed ID: 9065923
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen for the prevention of breast cancer.
Greenspan EM
Am J Med; 1996 Jun; 100(6):665. PubMed ID: 8678089
[No Abstract] [Full Text] [Related]
17. Endometrial changes with chronic tamoxifen use.
Loret de Mola JR
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
[TBL] [Abstract][Full Text] [Related]
18. Overview of the main outcomes in breast-cancer prevention trials.
Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P
Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen therapy--long-term results and complications.
Moore MP; Kinne DW
Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
[No Abstract] [Full Text] [Related]
20. Tamoxifen and secondary tumours. An update.
Wilking N; Isaksson E; von Schoultz E
Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]